Tempest Therapeutics, Inc. (TPST:NASDAQ) closed at $0.511 on October 23, 2026, down 2.16% on the day. The stock trades 95.4% below its 52-week high of $11.13 and 1.4% above its 52-week low of $0.504. Over the past year, it lost 95.2%. Tempest Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, TPST closed higher on 91 days (36%). Its best day was September 16, 2026 (+60.26%) and its worst was November 19, 2025 (-48.59%). The stock moved 10% or more in a single session 22 times. It opened at least 5% above the previous day's high 2 times.
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.
Find more stocks like TPST with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.